We used two recently described genetic markers in the region of the Friedreich's ataxia locus to study 33 affected pedigrees from central-southern regions of Italy. These markers are predicted, by physical mapping, to be localised more closely to the Friedreich's ataxia locus than other previously described markers. No recombination was found between these markers and the disease locus. Strong linkage disequilibrium is present between the compound haplotype and the disease locus. Since this population was also previously studied by using three other more distal genetic markers, a total of five markers has been used to identify the extended haplotype. Homozygosity in consanguineous pedigrees was also studied. Extended haplotype analysis and homozygosity studies suggest the presence of few common disease causing mutations in our population.
Abstract
We used two recently described genetic markers in the region of the Friedreich's ataxia locus to study 33 affected pedigrees from central-southern regions of Italy. These markers are predicted, by physical mapping, to be localised more closely to the Friedreich's ataxia locus than other previously described markers. No recombination was found between these markers and the disease locus. Strong linkage disequilibrium is present between the compound haplotype and the disease locus. Since this population was also previously studied by using three other more distal genetic markers, a total of five markers has been used to identify the extended haplotype. Homozygosity in consanguineous pedigrees was also studied. Extended haplotype analysis and homozygosity studies suggest the presence of few common disease causing mutations in our population. Friedreich's ataxia (FRDA according to the GDB nomenclature) is a relatively rare autosomal recessive degenerative disorder which usually manifests before adolescence.' It is characterised by relentlessly progressive gait and limb ataxia, loss of position sense and of tendon reflexes in the lower limbs, dysarthria, kyphoscoliosis, pes cavus, hypertrophic cardiomyopathy, and increased risk of diabetes mellitus.
The birth incidence of FRDA in Italy as a whole has been estimated to be between 1/ 22 000 and 1/25 000. 2 The FRDA locus has been assigned to 9q13-q21.1 by genetic linkage to the anonymous DNA marker MCT112 (D9S15).34 During the last four years, efforts to isolate the disease gene have included the cloning of several other genetic markers."' Detailed physical maps of the region, in both genomic DNA and yeast artificial chromosome clones, have shown the chromosomal order of these markers to be GS4(D9S 1 11)-80 kb-MCT1 12/MS(D9S15)-70 kb-GS2(D9S 110)-160 kb-26P(D9S5).89
By using a linkage disequilibrium approach we suggested that the FRDA locus is probably located at the 26P side of this cluster of markers'0 and in a recent collaborative study we reported the evidence of genetic recombination events that position the FRDA locus out of the cluster, at the 26P side." These findings concentrated the efforts to isolate markers in the genomic region proximal to that covered by the markers described at the 26P side. Two microsatellite markers, FD1 (Xll) and MLS1 (D9S202), were thus identified. '2'3 These markers are located respectively at 80 kb and 190 kb from 26P.
In the present study we used these two markers to study 132 The oligoprimer sequences are as follows (S = sense, A = antisense):
PCR product sizes (more frequent allele) were as follows: MLS I = 201 bp; FD 1 = 230 bp.
PCR products were loaded on 6% polyacrylamide-urea gels and analysed by autoradiography. Alternatively, PCR cold products were detected, after blotting on a nylon membrane and hybridisation with DIG labelled probes, by chemiluminescent and colorimetric methods (Pianese et al, manuscript in preparation). 
